Brief: Orchid Pharma gets final USFDA nod for Rasagiline Generic Formulation
17/03/2016 07:42
March 17 (Reuters) - Orchid Pharma Ltd ORCD.NS : * Gets final USFDA nod for rasagiline generic formulation * Source text: http://bit.ly/1pvEFA3 * Further company coverage ORCD.NS ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices